Processa Pharmaceuticals, Inc. Assets, Noncurrent
Processa Pharmaceuticals, Inc. (PCSA) had Assets, Noncurrent of $1.27 million as of 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2025-03-20
- 2024-12-31: Assets, Noncurrent $1.27M.
- 2022-12-31: Assets, Noncurrent $233.12K.
- 2021-12-31: Assets, Noncurrent $8.14M.
| Period end | Assets, Noncurrent |
|---|---|
| 2024-12-31 | $1.27M 10-K · filed 2025-03-20 |
| 2022-12-31 | $233.12K 10-K · filed 2023-03-30 |
| 2021-12-31 | $8.14M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |